Rely on the LIFEPAK 15 monitor/defibrillator for the confidence you need in emergencies and the highest available escalating energy, up to 360 joules (360J).
With six decades of serving EMS professionals, this LIFEPAK TOUGH tool helps skilled teams boost their performance and improve patient outcomes.
Take advantage of escalating energy up to 360J—which has been shown to improve conversion rates for difficult-to-defibrillate patients.1-4 Elevate STEMI care with the University of Glasgow ECG Analysis Program and ST-segment trend monitoring, which continuously monitors all 12-leads, alerting you to changes.
From intuitive controls to a dual-battery system and a large 21.3 cm anti-reflective color display that changes to high-contrast mode with a single button, the LIFEPAK 15 helps you work more efficiently so you can keep your focus on your patients.
With more than a dozen durability enhancements from the previous generation of LIFEPAK devices, the LIFEPAK 15 is our toughest yet – built to withstand drops, shocks, and extreme vibration.
The LIFENET System connects the LIFEPAK 15 through the cloud to transmit emergent patient data to the hospital while enabling ease of documentation, care team activation for time-sensitive emergencies, and valuable insights to support continuous performance improvement.
Help ensure the device is always ready to go with two reliable batteries and a daily self-test that alerts you to possible issues before you experience them in the field. Easily track device health and readiness via your LIFENET Asset management system.
*Kern KB, Stickney RE, Gallison L, Smith R. Metronome improves compression and ventilation rates during CPR on a manikin in a randomized trial. Resuscitation. 2010;81:206-210
Jeffrey Goodloe, MD, NREMT-P, FACEP
Medical Director for Medical Control Board Oklahoma City-Tulsa area EMS system
When you invest in our lifesaving devices and data products, you are buying more than quality design and manufacturing—you’re also buying our unrivaled commitment to customer service and support.
1. Stiell I, Walker R, Nesbitt L, et al. Biphasic trial a randomized comparison of fixed lower versus escalating higher energy levels for defibrillation in out-of-hospital cardiac arrest. Circulation. 2007;115:1511-1517.
2. Walker G, Koster R, Sun C, et al. Defibrillation probability and impedance change between shocks during resuscitation from out-of-hospital cardiac arrest. Resuscitation. 2009;80:773-777.
3. Koster R, Walker R, Chapman F. Recurrent ventricular fibrillation during advanced life support care of patients with prehospital cardiac arrest. Resuscitation. 2008;78:252-257.
4. Khaykin Y, Newman D, Kowalewski M, et al. Biphasic versus monophasic cardioversion in shock-resistant atrial fibrillation: a randomized clinical trial. Journal of Cardiovascular Electrophysiology. 2003;8(14);868-872.
This document is intended solely for the use of healthcare professionals. A healthcare professional must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that healthcare professionals be trained in the use of any particular product before using it.
The information presented is intended to demonstrate Stryker’s product offerings. A healthcare professional must always refer to operating instructions for complete directions for use indications, contraindications, warnings, cautions, and potential adverse events, before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your representative if you have questions about the availability of Stryker’s products in your area. Specifications subject to change without notice. The products depicted are CE marked in accordance with applicable EU Regulations and Directives.
Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: LIFEPAK, LIFENET, LUCAS, HealthEMS, RevNet, CODE-STAT, Physio-Control, HeartSine, samaritan, LIFEPAK CR, TrueCPR, REDI-CHARGE, QUIK-COMBO, EDGE, cprINSIGHT, ClearVoice, QUIK-STEP, LIFEPAK TOUGH, HomeSolutions.net, RELI, REDI-PAK, Shock Advisory System, LIFELINKcentral. All other trademarks are trademarks of their respective owners or holder. The yellow and black color scheme is a registered trademark of Stryker Corporation.
LIFEPAK devices: CE Class IIb (0123)
HeartSine device: CE Class IIb (0123)
LUCAS device: CE Class IIb (2460)
EC REP: Stryker European Operations Limited | Anngrove, IDA Business & Technology Park | Carrigtwohill, Co. Cork, T45 HX08 | Ireland